Oral ingestion of the environmental toxicant trichloroethylene in rats induces alterations in the gut microbiome: relevance to idiopathic Parkinson’s disease

Microbial alterations within the gut microbiome appear to be a common feature of individuals with Parkinson’s disease (PD), providing further evidence for the role of the gut-brain axis in PD development. As a major site of contact with the environment, questions have emerged surrounding the cause and effect of alterations to the gut microbiome by environmental contaminants associated with PD risk, such as pesticides, metals, and organic solvents. Recent data from our lab shows that ingestion of the industrial byproduct and environmental pollutant trichloroethylene (TCE) induces key Parkinsonian pathology within aged rats, including the degeneration of dopaminergic neurons, α-synuclein accumulation, neuroinflammation, and endolysosomal deficits. As TCE is the most common organic contaminant within drinking water, we postulated that ingestion of TCE associated with PD-related neurodegeneration may alter the gut microbiome to a similar extent as observed in persons with PD. To assess this, we collected fecal samples from adult rats treated with 200 mg/kg TCE over 6 weeks via oral gavage – the dose that produced nigrostriatal neurodegeneration – and analyzed the gut microbiome via whole genome shotgun sequencing. Our results showed changes in gut microorganisms reflective of the microbial signatures observed in individuals with idiopathic PD, such as decreased abundance of short-chain fatty acid producing Blautia and elevated lactic-acid producing Bifidobacteria, as well as genera who contain species previously reported as opportunistic pathogens such as Clostridium. From these experimental data, we postulate that TCE exposure within contaminated drinking water could induce alterations of the gut microbiome that contributes to chronic disease risk, including idiopathic PD.

[1]  B. Bhushan,et al.  Persistent organic pollutants in foods, their interplay with gut microbiota and resultant toxicity. , 2022, The Science of the total environment.

[2]  T. Milewicz,et al.  Differences in the Composition of Gut Microbiota between Patients with Parkinson’s Disease and Healthy Controls: A Cohort Study , 2021, Journal of clinical medicine.

[3]  K. Ohno,et al.  Altered gut microbiota in Parkinson's disease patients with motor complications. , 2021, Parkinsonism & related disorders.

[4]  J. Raes,et al.  Temporal variability in quantitative human gut microbiome profiles and implications for clinical research , 2021, Nature Communications.

[5]  B. B. Finlay,et al.  Gut microbiome in Parkinson's disease: New insights from meta-analysis. , 2021, Parkinsonism & related disorders.

[6]  Liangwei Mao,et al.  Cross-Sectional Study on the Gut Microbiome of Parkinson’s Disease Patients in Central China , 2021, Frontiers in Microbiology.

[7]  Zachary D. Wallen,et al.  Exploring human-genome gut-microbiome interaction in Parkinson’s disease , 2021, NPJ Parkinson's disease.

[8]  Gangduo Wang,et al.  Gut microbiome-host interactions in driving environmental pollutant trichloroethene-mediated autoimmunity. , 2021, Toxicology and applied pharmacology.

[9]  D. Berg,et al.  Gut microbiome signatures of risk and prodromal markers of Parkinson's disease. , 2021, Annals of neurology.

[10]  K. Murros,et al.  Desulfovibrio Bacteria Are Associated With Parkinson’s Disease , 2021, Frontiers in Cellular and Infection Microbiology.

[11]  B. Racette,et al.  Solvent exposed occupations and risk of Parkinson disease in Finland , 2021, Clinical parkinsonism & related disorders.

[12]  I. Charles,et al.  Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation , 2021, NPJ Parkinson's disease.

[13]  B. D. De Miranda,et al.  The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson's disease , 2020, Neurobiology of Disease.

[14]  C. Rajput,et al.  Is Gut Dysbiosis an Epicenter of Parkinson’s Disease? , 2021, Neurochemical Research.

[15]  Wei Chen,et al.  Blautia—a new functional genus with potential probiotic properties? , 2021, Gut microbes.

[16]  Irving E. Vega,et al.  Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson’s Disease , 2021, Metabolites.

[17]  K. Murros Sulfate reducing gut bacteria and Parkinson's disease , 2020, European journal of neurology.

[18]  K. Gokulan,et al.  Sex-Dependent Effects on Liver Inflammation and Gut Microbial Dysbiosis After Continuous Developmental Exposure to Trichloroethylene in Autoimmune-Prone Mice , 2020, Frontiers in Pharmacology.

[19]  Cuidan Li,et al.  Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical features. , 2020, Parkinsonism & related disorders.

[20]  Irving E. Vega,et al.  Gut microbiome dysbiosis is associated with elevated toxic bile acids in Parkinson’s disease , 2020, bioRxiv.

[21]  Lanjuan Li,et al.  Alterations of the Human Gut Microbiome in Chronic Kidney Disease , 2020, Advanced science.

[22]  N. Pedersen,et al.  Clostridium difficile infection and risk of Parkinson's disease: a Swedish population‐based cohort study , 2020, European journal of neurology.

[23]  Ronan M. T. Fleming,et al.  Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions , 2020, BMC Biology.

[24]  Zhaobo Chen,et al.  Trichloroethylene inhibits nitrogen transformation and microbial community structure in Mollisol , 2020, Ecotoxicology.

[25]  B. Zheng,et al.  Distribution characteristics and health risk assessment of volatile organic compounds in the groundwater of Lanzhou City, China , 2020, Environmental Geochemistry and Health.

[26]  Zachary D. Wallen,et al.  Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens , 2020, npj Parkinson's Disease.

[27]  H. Weiner,et al.  The sex-specific interaction of the microbiome in neurodegenerative diseases , 2019, Brain Research.

[28]  B. Zhu,et al.  Analysis of the Gut Microflora in Patients With Parkinson's Disease , 2019, Front. Neurosci..

[29]  L. Moulin,et al.  Genomic analyses of Burkholderia cenocepacia reveal multiple species with differential host-adaptation to plants and humans , 2019, BMC Genomics.

[30]  Guohong Cui,et al.  Gut Microbiota Differs Between Parkinson’s Disease Patients and Healthy Controls in Northeast China , 2019, Front. Mol. Neurosci..

[31]  E. Chuang,et al.  Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease , 2019, Journal of Neuroinflammation.

[32]  Rachael V. Phillips,et al.  Human exposure to trichloroethylene is associated with increased variability of blood DNA methylation that is enriched in genes and pathways related to autoimmune disease and cancer , 2019, Epigenetics.

[33]  E. Pekkonen,et al.  Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression , 2019, EBioMedicine.

[34]  G. Diamond,et al.  Toxicological profile for trichloroethylene (TCE) , 2019 .

[35]  C. Sue,et al.  Parkinson’s disease and the gastrointestinal microbiome , 2019, Journal of Neurology.

[36]  C. Consolandi,et al.  Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism , 2018, Movement disorders : official journal of the Movement Disorder Society.

[37]  M. Ota,et al.  Bifidobacterium and Lactobacillus Counts in the Gut Microbiota of Patients With Bipolar Disorder and Healthy Controls , 2019, Front. Psychiatry.

[38]  K. Gokulan,et al.  Irreversible effects of trichloroethylene on the gut microbial community and gut‐associated immune responses in autoimmune‐prone mice , 2018, Journal of applied toxicology : JAT.

[39]  Hongwei Zhou,et al.  Gut microbiota in patients with Parkinson's disease in southern China. , 2018, Parkinsonism & related disorders.

[40]  J. Jeong,et al.  Trichloroethylene and Parkinson’s Disease: Risk Assessment , 2018, Molecular Neurobiology.

[41]  M. Mohajeri,et al.  Changes of Colonic Bacterial Composition in Parkinson’s Disease and Other Neurodegenerative Diseases , 2018, Nutrients.

[42]  B. Pakkenberg,et al.  Inflammatory bowel disease increases the risk of Parkinson’s disease: a Danish nationwide cohort study 1977–2014 , 2018, Gut.

[43]  Chunyan Wu,et al.  Alteration of the fecal microbiota in Chinese patients with Parkinson’s disease , 2018, Brain, Behavior, and Immunity.

[44]  A. Heintz‐Buschart,et al.  The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder , 2017, Movement disorders : official journal of the Movement Disorder Society.

[45]  James T. Morton,et al.  Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome , 2017, Movement disorders : official journal of the Movement Disorder Society.

[46]  Luis Pedro Coelho,et al.  Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patients , 2017, Genome Medicine.

[47]  V. Govorun,et al.  Analysis of Gut Microbiota in Patients with Parkinson’s Disease , 2017, Bulletin of Experimental Biology and Medicine.

[48]  F. Guarino,et al.  Use of Zea mays L. in phytoremediation of trichloroethylene , 2017, Environmental Science and Pollution Research.

[49]  M. Tansey,et al.  The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis? , 2017, npj Parkinson's Disease.

[50]  R. Colwell,et al.  Enrichment dynamics of Listeria monocytogenes and the associated microbiome from naturally contaminated ice cream linked to a listeriosis outbreak , 2016, BMC Microbiology.

[51]  K. Fassbender,et al.  Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls. , 2016, Parkinsonism & related disorders.

[52]  I. Rusyn,et al.  Target Organ Metabolism, Toxicity, and Mechanisms of Trichloroethylene and Perchloroethylene: Key Similarities, Differences, and Data Gaps , 2016, The Journal of Pharmacology and Experimental Therapeutics.

[53]  D. Dalvie,et al.  Cytochrome P450 and Non–Cytochrome P450 Oxidative Metabolism: Contributions to the Pharmacokinetics, Safety, and Efficacy of Xenobiotics , 2016, Drug Metabolism and Disposition.

[54]  R. Colwell,et al.  Cross-talk among flesh-eating Aeromonas hydrophila strains in mixed infection leading to necrotizing fasciitis , 2016, Proceedings of the National Academy of Sciences.

[55]  K. Ohno,et al.  Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson’s Disease , 2015, PloS one.

[56]  Ali Keshavarzian,et al.  Colonic bacterial composition in Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[57]  E. Pekkonen,et al.  Gut microbiota are related to Parkinson's disease and clinical phenotype , 2015, Movement disorders : official journal of the Movement Disorder Society.

[58]  Rob Knight,et al.  Longitudinal analysis of microbial interaction between humans and the indoor environment , 2014, Science.

[59]  Rita R. Colwell,et al.  Microbial Community Profiling of Human Saliva Using Shotgun Metagenomic Sequencing , 2014, PloS one.

[60]  J. Schnoor,et al.  Biodegradation of mono-hydroxylated PCBs by Burkholderia xenovorans , 2012, Biotechnology Letters.

[61]  C. Tanner,et al.  Solvent exposures and parkinson disease risk in twins , 2012, Annals of neurology.

[62]  G. Bing,et al.  Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344 rats , 2010, Journal of neurochemistry.

[63]  Sara Khan,et al.  Effect of trichloroethylene (TCE) toxicity on the enzymes of carbohydrate metabolism, brush border membrane and oxidative stress in kidney and other rat tissues. , 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[64]  N. Hisanaga,et al.  Occupational trichloroethylene exposure as a cause of idiosyncratic generalized skin disorders and accompanying hepatitis similar to drug hypersensitivities , 2007, International archives of occupational and environmental health.

[65]  D. Putt,et al.  Metabolism and Tissue Distribution of Orally Administered Trichloroethylene in Male and Female Rats: Identification of Glutathione- and Cytochrome P-450-Derived Metabolites in Liver, Kidney, Blood, and Urine , 2006, Journal of toxicology and environmental health. Part A.

[66]  G. Sakorafas,et al.  Hepatitis caused by occupational chronic exposure to trichloroethylene. , 2004, Acta gastro-enterologica Belgica.

[67]  C. Paulu,et al.  Tetrachloroethylene-contaminated drinking water in Massachusetts and the risk of colon-rectum, lung, and other cancers. , 1999, Environmental health perspectives.

[68]  A. Zuckerman,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.

[69]  한범수,et al.  Trichloroethylene , 1994, Reactions Weekly.

[70]  J. Gossett,et al.  Biological reductive dechlorination of tetrachloroethylene and trichloroethylene to ethylene under methanogenic conditions , 1989, Applied and environmental microbiology.

[71]  A. Keshavarzian,et al.  The gut microbiome in Parkinson's disease: A culprit or a bystander? , 2020, Progress in brain research.

[72]  K. Shannon,et al.  The Potential Role of Gut-Derived Inflammation in Multiple System Atrophy. , 2017, Journal of Parkinson's disease.

[73]  Iarc Monographs,et al.  TRICHLOROETHYLENE, TETRACHLOROETHYLENE, AND SOME OTHER CHLORINATED AGENTS. , 2014, IARC monographs on the evaluation of carcinogenic risks to humans.

[74]  F. Sitas IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (incl Sitas F.) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. A Review of Human Carcinogens , 2011 .